Loading...
Chemical structure of Acumapimod

GC19019

Acumapimod

Also known as 3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 uM for p38α

ChemicalCAS836683-15-9MW385.42FormulaC22H19N5O2
CAS number
836683-15-9
Molecular weight
385.42
Formula
C22H19N5O2
Solubility
DMSO ： ≥ 50 mg/mL (129·73 mM)
InChIKey
VGUSQKZDZHAAEE-UHFFFAOYSA-N
Catalogue number
GC19019
Brand
GLPBIO
Computed properties PubChem CID 11338127 · XLogP 3.4 · TPSA 114 Ų · H-bond donors 2
XLogP
3.4
TPSA
114 Ų
H-bond donors
2
H-bond acceptors
5
Rotatable bonds
5
Heavy atoms
29

SMILES CC1=C(C=C(C=C1)C(=O)NC2CC2)N3C(=C(C=N3)C(=O)C4=CC=CC(=C4)C#N)N

Computed descriptors from PubChem (CID 11338127), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.